Evidence map›Paper›PMID 33833446›Full record

ArticleNature chemistry2021

Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.

Nicholas Favalli, Gabriele Bassi, Christian Pellegrino, Jacopo Millul, Roberto De Luca, Samuele Cazzamalli, Su Yang, Anika Trenner, Nour L Mozaffari, Renier Myburgh and 8 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. FSOACS medicinal chemistry letters · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Small-molecule discovery through DNA-encoded libraries.Nature reviews. Drug discovery · 2023
    Review
  18. Review
  19. Review
  20. Structural insights into the interaction of three Y-shaped ligands with PI3Kα.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Nicholas FavalliDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6538-7379
Gabriele BassiDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland.ORCID http://orcid.org/0000-0002-9439-8624
Christian PellegrinoDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7898-9988
Jacopo MillulPhilochem AG, Otelfingen, Switzerland.ORCID http://orcid.org/0000-0003-4288-1283
Roberto De LucaPhilochem AG, Otelfingen, Switzerland.
Samuele CazzamalliPhilochem AG, Otelfingen, Switzerland.ORCID http://orcid.org/0000-0003-0510-5664
Su YangDepartment of Molecular Medicine, Scripps Research Institute, La Jolla, CA, USA.
Anika TrennerInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2521-8765
Nour L MozaffariInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4129-7459
Renier MyburghDepartment of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland.
Mustafa MorogluDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK.
Stuart J ConwayDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5148-117X
Alessandro A SartoriInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2770-0333
Markus G ManzDepartment of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4676-7931
Richard A LernerDepartment of Chemistry, Scripps Research Institute, La Jolla, CA, USA.
Peter K VogtDepartment of Molecular Medicine, Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4519-7500
Jörg ScheuermannDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland. joerg.scheuermann@pharma.ethz.ch.ORCID http://orcid.org/0000-0001-7746-4717
Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland. dario.neri@pharma.ethz.ch.ORCID http://orcid.org/0000-0001-5234-7370
ETH Zurich · CHUniversity of Zurich · CHPhilochem (Switzerland) · CHScripps Research Institute · USUniversity of Oxford · GB

Funding

Cancer genes: translating basics to applicationsR35CA197582 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2016 to 2022
$7.8M
NCI NIH HHS R35 CA197582
6 · The paper itself

Abstract

The encoding of chemical compounds with amplifiable DNA tags facilitates the discovery of small-molecule ligands for proteins. To investigate the impact of stereo- and regiochemistry on ligand discovery, we synthesized a DNA-encoded library of 670,752 derivatives based on 2-azido-3-iodophenylpropionic acids. The library was selected against multiple proteins and yielded specific ligands. The selection fingerprints obtained for a set of protein targets of pharmaceutical relevance clearly showed the preferential enrichment of ortho-, meta- or para-regioisomers, which was experimentally verified by affinity measurements in the absence of DNA. The discovered ligands included novel selective enzyme inhibitors and binders to tumour-associated antigens, which enabled conditional chimeric antigen receptor T-cell activation and tumour targeting.

Indexed as

Drug Delivery SystemsAnimalsCell Line, TumorDNADrug DiscoveryFluorescenceGene LibraryHumansImmunoglobulin Variable RegionMiceMicroscopy, FluorescenceNeoplasmsNeoplasms, ExperimentalReceptors, Chimeric AntigenT-LymphocytesDNAImmunoglobulin Variable RegionReceptors, Chimeric Antigen

Identifiers

PMID33833446
PMCPMC8405038
OpenAlexW3151660804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.